DASATINIB


DASATINIB

Drug action

Dasatinib is a tyrosine kinase inhibitor.

Indications and dose

Chronic phase chronic myeloid leukaemia (initiated by a specialist)

Acute lymphoblastic leukaemia [in combination with ...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×